Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
SEC Accession No. 0001193125-25-280501
Filing Date
2025-11-13
Accepted
2025-11-13 17:13:00
Documents
22
Effectiveness Date
2025-11-13

Document Format Files

Seq Description Document Type Size
1 S-3ASR d61128ds3asr.htm S-3ASR 425584
2 EX-1.1 d61128dex11.htm EX-1.1 221262
3 EX-4.3 d61128dex43.htm EX-4.3 348742
4 EX-4.4 d61128dex44.htm EX-4.4 334897
5 EX-4.5 d61128dex45.htm EX-4.5 39429
6 EX-4.6 d61128dex46.htm EX-4.6 39729
7 EX-5.1 d61128dex51.htm EX-5.1 28710
8 EX-23.1 d61128dex231.htm EX-23.1 1698
9 EX-FILING FEES d61128dexfilingfees.htm   iXBRL EX-FILING FEES 40246
10 GRAPHIC g61128g03a45.jpg GRAPHIC 55661
11 GRAPHIC g61128g53i32.jpg GRAPHIC 3856
  Complete submission text file 0001193125-25-280501.txt   1748642

Data Files

Seq Description Document Type Size
24 EXTRACTED XBRL INSTANCE DOCUMENT d61128dexfilingfees_htm.xml XML 20281
Mailing Address 195 CHURCH STREET 16TH FLOOR NEW HAVEN CT 06510
Business Address 195 CHURCH STREET 16TH FLOOR NEW HAVEN CT 06510 203-304-2499
Trevi Therapeutics, Inc. (Filer) CIK: 0001563880 (see all company filings)

EIN.: 450834299 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3ASR | Act: 33 | File No.: 333-291517 | Film No.: 251479730
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)